What Pediatric Endocrinologists Need to Know About Diabetes in the Age of GLP-1s
What Pediatric Endocrinologists Need to Know About Diabetes in the Age of GLP-1s https://pediatricsnationwide.org/wp-content/uploads/2024/05/AdobeStock_9857146-1024x683.jpg 1024 683 Erin Gregory https://secure.gravatar.com/avatar/?s=96&d=mm&r=gGLP-1 receptor agonists such as Ozempic (semaglutide) offer new opportunities for managing pediatric diabetes and obesity. These medications target insulin resistance and related comorbidities, but their use raises questions about safety, access and ethical considerations. In the following interview, Leena Mamilly, MD, and Rohan…
read more